[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:erbb3-gene":3},{"name":4,"total":5,"recruiting":5,"trials":6},"ERBB3 Gene",1,[7],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT05828069","A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis",[11],"Phase 2","RECRUITING","2026-08-26T02:16:16.995720Z","2026-05-05T02:43:29.729634Z"]